Envestnet Asset Management Inc Genmab A/S Transaction History

Envestnet Asset Management Inc

$324 Billion
Q3 2025

A detailed history of Envestnet Asset Management Inc transactions in Genmab A/S stock. As of the latest transaction made, Envestnet Asset Management Inc holds 809,939 shares of GMAB stock, worth $23.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

809,939

Previous 749,603 8.05%

Holding current value

$23.2 Million

Previous $15.5 Million 60.4%

% of portfolio

0.01%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	BUY	$20.3 - $30.67 $1.22 Million - $1.85 Million	60,336 Added 8.05%	809,939 $24.8 Million
Q2 2025 Jul 31, 2025	BUY	$17.98 - $23.09 $238,720 - $306,565	13,277 Added 1.8%	749,603 $15.5 Million
Q1 2025 Apr 29, 2025	BUY	$18.69 - $24.14 $234,466 - $302,836	12,545 Added 1.73%	736,326 $14.4 Million
Q4 2024 Feb 12, 2025	SELL	$20.02 - $24.15 $6.4 Million - $7.72 Million	-319,779 Reduced 30.64%	723,781 $15.1 Million
Q3 2024 Nov 06, 2024	BUY	$23.84 - $28.48 $1.14 Million - $1.36 Million	47,893 Added 4.81%	1,043,560 $25.4 Million
Q2 2024 Aug 08, 2024	SELL	$25.13 - $30.27 $665,015 - $801,035	-26,463 Reduced 2.59%	995,667 $25 Million
Q1 2024 May 13, 2024	BUY	$26.43 - $32.77 $2.54 Million - $3.15 Million	96,212 Added 10.39%	1,022,130 $30.6 Million
Q4 2023 Feb 13, 2024	SELL	$27.94 - $35.44 $585,678 - $742,893	-20,962 Reduced 2.21%	925,918 $29.5 Million
Q3 2023 Nov 13, 2023	BUY	$35.27 - $42.24 $16.1 Million - $19.3 Million	457,772 Added 93.59%	946,880 $33.4 Million
Q2 2023 Aug 04, 2023	SELL	$37.4 - $42.94 $23.2 Million - $26.7 Million	-620,763 Reduced 55.93%	489,108 $18.6 Million
Q1 2023 May 11, 2023	BUY	$34.88 - $43.22 $20.4 Million - $25.3 Million	585,924 Added 111.83%	1,109,871 $41.9 Million
Q4 2022 Feb 07, 2023	BUY	$33.8 - $47.06 $590,925 - $822,749	17,483 Added 3.45%	523,947 $22.2 Million
Q3 2022 Nov 10, 2022	BUY	$31.52 - $373.61 $4.31 Million - $51 Million	136,616 Added 36.94%	506,464 $16.3 Million
Q2 2022 Aug 03, 2022	SELL	$26.83 - $38.57 $1.42 Million - $2.04 Million	-52,895 Reduced 12.51%	369,848 $12 Million
Q1 2022 May 04, 2022	SELL	$30.95 - $39.68 $1.15 Million - $1.48 Million	-37,180 Reduced 8.08%	422,743 $15.3 Million
Q4 2021 Feb 04, 2022	BUY	$35.87 - $47.12 $1.11 Million - $1.45 Million	30,852 Added 7.19%	459,923 $18.2 Million
Q3 2021 Oct 07, 2021	SELL	$41.55 - $48.72 $6.68 Million - $7.83 Million	-160,740 Reduced 27.25%	429,071 $18.8 Million
Q2 2021 Aug 04, 2021	BUY	$32.88 - $44.57 $903,213 - $1.22 Million	27,470 Added 4.88%	589,811 $24.1 Million
Q1 2021 May 04, 2021	BUY	$30.92 - $44.4 $2.96 Million - $4.25 Million	95,820 Added 20.54%	562,341 $18.5 Million
Q4 2020 Feb 02, 2021	BUY	$33.66 - $40.76 $7.97 Million - $9.65 Million	236,741 Added 103.03%	466,521 $19 Million
Q3 2020 Oct 09, 2020	BUY	$33.07 - $38.68 $1.83 Million - $2.14 Million	55,268 Added 31.67%	229,780 $8.41 Million
Q2 2020 Jul 08, 2020	BUY	$20.05 - $33.89 $289,983 - $490,151	14,463 Added 9.04%	174,512 $5.91 Million
Q1 2020 Apr 23, 2020	BUY	$17.15 - $25.22 $376,373 - $553,478	21,946 Added 15.89%	160,049 $3.39 Million
Q4 2019 Feb 11, 2020	BUY	$18.88 - $24.14 $93,493 - $119,541	4,952 Added 3.72%	138,103 $3.08 Million
Q3 2019 Oct 17, 2019	BUY	$18.0 - $21.38 $2.4 Million - $2.85 Million	133,151 New	133,151 $2.7 Million

Others Institutions Holding GMAB

# of Institutions

257

Shares Held

65M

Call Options Held

32.5K

Put Options Held

55K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $18.9B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Genmab A/S Transaction History